Patrick McIlvenny
Comptroller/Controller/Auditor chez HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Profil
Patrick McIlvenny is currently working as the Chief Accounting Officer & Senior Vice President at Horizon Therapeutics Plc.
He started this position in 2022.
Prior to his current job, Mr. McIlvenny pursued an undergraduate degree at the University of Ulster.
Postes actifs de Patrick McIlvenny
Sociétés | Poste | Début |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Comptroller/Controller/Auditor | 11/11/2022 |
Formation de Patrick McIlvenny
University of Ulster | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |